Oncology Medical News about adenosquamous carcinomas

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Molecular characterization of EGFR, PDGFRA and VEGFR-2 in cervical adenosquamous carcinoma
BMC Cancer, 07/01/09

Longatto-Filho A et al. - This is the most extensive analysis of EGFR, PDGFRA and VEGFR-2 in cervical adenosquamous carcinomas. Despite the absence of EGFR and PDGFRA activating mutations, the presence of overexpression of these three important therapeutic targets in a subset of cases may be important in predicting the sensitivity of adenosquamous carcinoma to specific anti-RTKs drugs.

<< Previous
A phase III clinical trial of exercise modalities on treatment...

Next >>
Influence of oral beclomethasone dipropionate on early...